The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of erdafitinib (ERDA) versus intravesical chemotherapy (IC) in patients with high-risk nonmuscle invasive bladder cancer (HR-NMIBC) with FGFR mutations or fusions, who recurred after Bacillus Calmette-Guérin (BCG) therapy.
 
Gary D. Steinberg
Honoraria - AstraZeneca; Baxter; BioCancell; Bristol-Myers Squibb; CG Oncology; Epivax Oncology; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Heat Biologics; Janssen Oncology; MDxHealth; Merck; Natera; Photocure; Roche/Genentech; Sesen Bio; Taris Biomedical; Telesta Therapeutics; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
Joan Palou-Redorta
Consulting or Advisory Role - Olympus
 
Juergen E. Gschwend
Honoraria - Bayer Schering Pharma; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Janssen-Cilag
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Yohann Loriot
Honoraria - Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Janssen; Janssen (Inst); MSD Oncology; MSD Oncology (Inst); Roche; Seagen
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); CureVac (Inst); Exelixis (Inst); Incyte (Inst); Janssen Oncology (Inst); Medivation (Inst); MSD Oncology (Inst); Nektar (Inst); Oncogenex (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Siamak Daneshmand
Honoraria - Ferring; MDxHealth; Olympus; pacific edge; Photocure; QED Therapeutics; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Morgan Roupret
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
Ademi E. Santiago-Walker
Employment - Janssen Research & Development
 
Julie C. Switzky
Employment - Janssen Research & Development
 
Christopher Major
Employment - Janssen Research & Development
 
Mahadi Baig
Employment - Janssen Research & Development
 
Qi Xia
Employment - Janssen Research & Development
 
James WF Catto
Honoraria - Abbott Laboratories
Speakers' Bureau - ASCO
Travel, Accommodations, Expenses - European Association of Urology